In gastric cancer, CMTM3 promotes the degradation of EGFR to impede tumor metastasis (Yuan et al., 2016), indicating that knocking out the CMTM3 gene can be a potential therapy for gastric cancer. Here, CMTM3 is linked to neoplasm.